| Autor: |
Torres-Martinez C; Universidad del Bosque Bogotá Colombia Universidad del Bosque, Bogotá, Colombia., Chaparro E; Departmento de Pediatría Hospital Cayetano Heredia Lima Peru Departmento de Pediatría, Hospital Cayetano Heredia, Lima, Peru., Mariño AC; Hospital Militar Central Bogotá Colombia Hospital Militar Central, Bogotá, Colombia., Falleiros-Arlant LH; Faculdade de Medicina da Universidade Metropolitana de Santos São Paulo Brazil Faculdade de Medicina da Universidade Metropolitana de Santos, São Paulo, Brazil., Camacho-Moreno G; Fundación Hospital Pediátrico la Misericordia (HOMI) Bogotá Colombia Fundación Hospital Pediátrico la Misericordia (HOMI), Bogotá, Colombia., Castillo ME; Facultad de Medicina Universidad Peruana Cayetano Heredia Lima Peru Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru., Garces C; Universidad de Antioquia Clínica las Américas Auna Antioquia Colombia Universidad de Antioquia, Clínica las Américas Auna, Antioquia, Colombia., Coronell W; Universidad de Cartagena Cartagena Colombia Universidad de Cartagena, Cartagena, Colombia., Somocurcio R; Pediatría Clínica Anglo Americana Lima Peru Pediatría Clínica Anglo Americana, Lima, Peru. |
| Abstrakt: |
The objective of this article was to consider the vaccination challenges in Colombia and Peru and the role of pediatric combination vaccines in overcoming these challenges. Barriers to including new vaccines with more antigens remain apparent in parts of these countries, where vaccine-preventable diseases in infants continue to be a major problem. The challenges include the heterogeneity of vaccine coverage within each country and in neighboring countries, which can contribute to poor rates of vaccination coverage; the adverse impact of the inward migration of unvaccinated individuals, which has favored the re-emergence of vaccine-preventable diseases; vaccine shortages; and the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and the associated shifts in health care resources. To improve the coverage of pediatric vaccines in Colombia and Peru, it will be necessary to ensure the widespread integration into vaccine schedules of combination vaccines containing diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b and hepatitis B antigens with a three-dose primary series delivered at 2, 4 and 6 months of age followed by a booster at 18 months of age. Such vaccines play important roles in preventing diphtheria, tetanus and pertussis; eradicating polio; and providing boosting against H. influenzae type b. |
